---
title: "Nanjing Leads Biolabs Co., Ltd. (09887.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/09887.HK.md"
symbol: "09887.HK"
name: "Nanjing Leads Biolabs Co., Ltd."
industry: "Biotechnology"
---

# Nanjing Leads Biolabs Co., Ltd. (09887.HK)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | HK Market |
| Website | [www.leadsbiolabs.com](https://www.leadsbiolabs.com) |

## Company Profile

Nanjing Leads Biolabs Co., Ltd., a clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide. It develops therapies in oncology, autoimmune, and other severe diseases. The company’s lead product LBL-024, a PD-L1/4-1BB bispecif...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -41.36 | 53/70 | - | - | - |
| PB | 113.29 | 61/70 | 111.30 | 96.77 | 86.56 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-09T16:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 50% |
| Overweight | 1 | 25% |
| Hold | 1 | 25% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 65.50 |
| Highest Target | 95.35 |
| Lowest Target | 58.99 |

## References

- [Company Overview](https://longbridge.com/en/quote/09887.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/09887.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/09887.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.